Results 271 to 280 of about 112,477 (323)
Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer
Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 25-34, January 2026.ABSTRACT Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile ...
Osamu Itano, Takuya Minagawa
wiley +1 more source
Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 229-240, January 2026.Sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) significantly improves both the volume and function of the future remnant liver (FRL) compared to PVE alone. In this study, the FRL regeneration rates for volume and function were markedly higher and faster in the PVE–HVE group, with no differences in surgical outcomes ...
Thanh Tung Lai +9 more
wiley +1 more source
Prevalence of gallstones and gallbladder disease in Canadian Micmac Indian women.
, 1977 C. N. Williams +2 more
openalex
Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 241-250, January 2026.This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka +9 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.Abstract INTRODUCTION Metabolic dysfunction–associated steatotic liver disease (MASLD) has been linked to adverse brain outcomes. We aim to evaluate whether MASLD is associated with cognitive impairment/decline. METHODS We analyzed data from the Estudo Longitudinal da Saúde do Adulto (ELSA‐Brasil study).
Raphael Machado Castilhos +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 119-135, January 2026.Ileal bile acid transporter inhibitors (IBATi), including maralixibat and odevixibat, are a novel approach to the treatment of paediatric cholestatic liver diseases, such as Alagille syndrome (ALGS) and different forms of progressive familial intrahepatic cholestasis (PFIC).
Alise D. E. de Groot +5 more
wiley +1 more source
BioFactors, Volume 52, Issue 1, January/February 2026.Primary bile acids synthesized in the liver are transformed by gut microbes into secondary bile acids that engage receptors such as FXR and TGR5, thereby modulating immune function and metabolic homeostasis. Dysregulation of these signaling pathways contributes to MASH, NAFLD, IBD, and neurodegenerative disorders, underscoring their relevance as ...
Simone Baldi +5 more
wiley +1 more source